Skip to main content
SpringerLink
Log in

Disorders of Pigmentation

  • Chapter
  • First Online:
Therapy in Pediatric Dermatology

  • 1404 Accesses

Abstract

This chapter provides an overview of the disorders of pigmentation that are most commonly seen by pediatricians, and highlights those conditions specifically requiring additional laboratory screening. The chapter is divided into four sections: congenital localized alterations in pigmentation (e.g. nevus depigmentosus), congenital generalized alterations in pigmentation (e.g. albinism), acquired localized alterations in pigmentation (e.g. tinea versicolor) and acquired generalized alterations in pigmentation (e.g. vitiligo). The first two categories are separated from the latter two by onset before the age of 2 years, in most cases.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 299.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Szabo G. The number of melanocytes in human epidermis. Br Med J. 1954;1:1016–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Tey HL. A practical classification of childhood hypopigmentation disorders. Acta Derm Venereol. 2010;90:6–11.

    Article  PubMed  Google Scholar 

  3. Cordova A. The Mongolian spot: a study of ethnic differences and review of the literature. Clin Pediatr (Phila). 1981;20:714–9.

    Article  CAS  Google Scholar 

  4. Monteagudo B, Labandeia J, Leon-Muinos E, Carballeira I, Corrales A, Cabanillas M, et al. Prevalence of birthmarks and transient skin lesions in 1,000 Spanish newborns. Actas Dermosifiliogr. 2011;102:264–9.

    Article  CAS  PubMed  Google Scholar 

  5. Nanda A, Kaur S, Bhakoo ON, Dhall K. Survey of cutaneous lesions in Indian newborns. Pediatr Dermatol. 1989;6:39–42.

    Article  CAS  PubMed  Google Scholar 

  6. Rybojad M, Moraillon I, Ogier de Baulny H, Prigent F, Morel P. Extensive Mongolian spot related to Hurler disease. Ann Dermatol Venereol. 1999;126:35–7. Article in French.

    CAS  PubMed  Google Scholar 

  7. Silverberg NB. Chapter 4: Normal color variations in children of color. In: Silverberg NB, Duran-McKinster C, Tay YK, editors. Pediatric skin of color. New York: Springer; 2015.

    Chapter  Google Scholar 

  8. Whitehouse D. Diagnostic value of the café-au-lait spot in children. Arch Dis Child. 1966;41:316.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. DeBella K, Szudek J, Friedman JM. Use of the national institutes of health criteria for diagnosis of neurofibromatosis 1 in children. Pediatrics. 2000;105:608–14.

    Article  CAS  PubMed  Google Scholar 

  10. Nunley KS, Gao F, Albers AC, Bayliss SJ, Gutmann DH. Predictive value of café au lait macules at initial consultation in the diagnosis of neurofibromatosis type I. Arch Dermatol. 2009;145:883–7.

    Article  PubMed  Google Scholar 

  11. Dhar S, Kanwar AJ, Kaur S. Nevus depigmentosus in India: experience with 50 patients. Pediatr Dermatol. 1993;10:299–300.

    Article  CAS  PubMed  Google Scholar 

  12. Silverberg NB. Chapter 4: Normal color variations in children of color. In: Silverberg NB, Duran-McKinster C, Tay YK, editors. Pediatric skin of color. New York: Springer; 2015.

    Chapter  Google Scholar 

  13. Nath J, Dubey A, Pavan R. Analysis of twenty pediatric cases of tuberous sclerosis complex: are we doing enough? Indian J Dermatol Venereol Leprol. 2015;81:23–8.

    Article  PubMed  Google Scholar 

  14. Northrup H, Krueger DA, International Tuberous Sclerosis Complex Consensus Group. Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 international tuberous sclerosis complex consensus conference. Pediatr Neurol. 2013;49:243–54.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Salido-Vallejo R, Garnacho-Saucedo G, Moreno-Giménez JC. Current options for the treatment of facial angiofibromas. Actas Dermosifiliogr. 2014;105(6):558–68.

    Article  CAS  PubMed  Google Scholar 

  16. Teng JM, Cowen EW, Wataya-Kaneda M, Gosnell ES, Witman PM, Hebert AA, et al. Dermatologic and dental aspects of the 2012 international tuberous sclerosis complex consensus statements. JAMA Dermatol. 2014;150(10):1095–101.

    Article  PubMed  Google Scholar 

  17. Cohen 3rd J, Shahrokh K, Cohen B. Analysis of 36 cases of Blaschkoid dyspigmentation: reading between the lines of Blaschko. Pediatr Dermatol. 2014;31:471–6.

    Article  PubMed  Google Scholar 

  18. Nehal KS, PeBenito R, Orlow SJ. Analysis of 54 cases of hypopigmentation and hyperpigmentation along the lines of Blaschko. Arch Dermatol. 1996;132:1167–70.

    Article  CAS  PubMed  Google Scholar 

  19. Cabrera HN, Della Giovanna P, Hermida MD. Syndromic nevoid hypermelanosis: description of seven cases with a 10-year follow up. J Dermatol. 2011;38:125–30.

    Article  PubMed  Google Scholar 

  20. Boente MC. Chapter 26: Becker’s nevus. In: Silverberg NB, Duran-McKinster C, Tay YK, editors. Pediatric skin of color. New York: Springer; 2015.

    Google Scholar 

  21. Patrizi A, Medri M, Raone B, Bianchi F, Aprile S, Neri I. Clinical characteristics of Becker’s nevus in children: report of 118 cases from Italy. Pediatr Dermatol. 2012;29:571–4.

    Article  PubMed  Google Scholar 

  22. Welsch MJ, Stein SL. A syndrome of hemimaxillary enlargement, asymmetry of the face, tooth abnormalities, and skin findings (HATS). Pediatr Dermatol. 2004;21:448–51.

    Article  PubMed  Google Scholar 

  23. Kar S, Preetha K, Yadav N, Madke B, Gangane N. Becker’s nevus with neurofibromatosis type 1. Ann Indian Acad Neurol. 2015;18:90–2.

    PubMed  PubMed Central  Google Scholar 

  24. Dasegowda SB, Basavaraj G, Nischal K, Swaroop M, Umashankar N, Swamy SS. Becker’s nevus syndrome. Indian J Dermatol. 2014;59:421.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Fehr B, Panizzon RG, Schnyder UW. Becker’s nevus and malignant melanoma. Dermatologica. 1991;182:77–80.

    Article  CAS  PubMed  Google Scholar 

  26. Lapidoth M, Adatto M, Cohen S, Ben-Amitai D, Halachmi S. Hypertrichosis in Becker’s nevus: effective low-fluence laser hair removal. Lasers Med Sci. 2014;29:191–3.

    Article  CAS  PubMed  Google Scholar 

  27. Bukvić Mokos Z, Lipozenčić J, Ceović R, Stulhofer Buzina D, Kostović K. Laser therapy of pigmented lesions: pro and contra. Acta Dermatovenerol Croat. 2010;18:185–9.

    PubMed  Google Scholar 

  28. Leong KF. Chapter 3: pigmentary development of East Asian children. In: Silverberg NB, Duran-McKinster C, Tay YK, editors. Pediatric skin of color. New York: Springer; 2015.

    Google Scholar 

  29. Samadian M, Nejad AM, Bakhtevari MH, Sabeti S, Sharifi G, Jabbari R, Rezaei O. Primary meningeal melanocytoma in the left temporal lobe associated with nevus ota: a case report and review of the literature. World Neurosurg. 2015 Apr 7. pii: S1878-8750(15)00358-7. doi: 10.1016/j.wneu.2015.03.061. [Epub ahead of print] Review.

  30. Shin D, Sinha M, Kondziolka DS, Kirkwood JM, Rao UN, Tarhini AA. Intermediate-grade meningeal melanocytoma associated with nevus of Ota: a case report and review of the literature. Melanoma Res. 2015 Apr 29. [Epub ahead of print]

    Google Scholar 

  31. Wen X, Li Y, Jiang X. A randomized, split-face clinical trial of Q-switched alexandrite laser versus Q-switched Nd:YAG laser in the treatment of bilateral Nevus of Ota. J Cosmet Laser Ther. 2015;12:1–16.

    Article  Google Scholar 

  32. Dessinioti C, Stratigos AJ, Rigopoulos D, Katsambas AD. A review of genetic disorders of hypopigmentation: lessons learned from the biology of melanocytes. Exp Dermatol. 2009;18:741–9.

    Article  CAS  PubMed  Google Scholar 

  33. Spitz JL. Genodermatoses: a clinical guide to genetic skin disorders. Philadelphia: Lippincott Williams & Wilkins; 2005.

    Google Scholar 

  34. Tomita Y, Suzuki T. Genetics of pigmentary disorders. Am J Med Genet C Semin Med Genet. 2004;131C:75–81.

    Article  PubMed  Google Scholar 

  35. Mitchell JJ, Trakadis YJ, Scriver CR. Phenylalanine hydroxylase deficiency. Genet Med. 2011;13:697–707.

    Article  CAS  PubMed  Google Scholar 

  36. Fistarol SK, Itin PH. Disorders of pigmentation. J Ger Soc Dermatol. 2010;8:187–202.

    Google Scholar 

  37. Somaraju UR, Merrin M. Sapropterin dihydrochloride for phenylketonuria. Cochrane Database Syst Rev. 2015;3:CD008005.

    Google Scholar 

  38. Vockley J, Andersson HC, Antshel KM, Braverman NE, Burton BK, Frazier DM, American College of Medical Genetics and Genomics Therapeutics Committee, et al. Phenylalanine hydroxylase deficiency: diagnosis and management guideline. Genet Med. 2014;16:188–200.

    Article  CAS  PubMed  Google Scholar 

  39. Boissy RE, Nordlund JJ. Molecular basis of congenital hypopigmentary disorders in humans: a review. Pigment Cell Res. 1997;10:12–24.

    Article  CAS  PubMed  Google Scholar 

  40. Fistarol SK, Itin PH. Disorders of pigmentation. J Ger Soc Dermatol. 2010;8:187–202.

    Google Scholar 

  41. Menasche G, Ho CH, Sanal O, Feldmann J, Tezcan I, Ersoy F, et al. Griscelli syndrome restricted to hypopigmentation results from a melanophilin defect (GS3) or a MY05A F-exon deletion (GS1). J Clin Invest. 2003;112:450–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Schuster F, Stachel DK, Schmid I, Baumeister FA, Graubner UB, Weiss M, et al. Griscelli syndrome: report of the first peripheral blood stem cell transplant and the role of mutations in the RAB27A gene as an indication for BMT. Bone Marrow Transplant. 2001;28:409–12.

    Article  CAS  PubMed  Google Scholar 

  43. Fistarol SK, Itin PH. Disorders of pigmentation. J Ger Soc Dermatol. 2010;8:187–202.

    Google Scholar 

  44. Fleishchman RA, Saltman DL. Deletion of the c-kit proto-oncogene in the human developmental defect piebald trait. Proc Natl Acad Sci U S A. 1991;88:10885–9.

    Article  Google Scholar 

  45. Paller AS, Mancini AJ. Disorders of pigmentation. In: Paller AS, Mancini AJ, editors. Hurwitz clinical pediatric dermatology: a textbook of skin disorders of childhood and adolescence. New York: Elsevier/Saunders; 2011. p. 238–44.

    Google Scholar 

  46. Spitz JL. Genodermatoses: a clinical guide to genetic skin disorders. Philadelphia: Lippincott Williams & Wilkins; 2005.

    Google Scholar 

  47. Spritz RA, Beighton P. Piebaldism with deafness: molecular evidence for an expanded syndrome. Am J Med Genet. 1998;75:101–3.

    Article  CAS  PubMed  Google Scholar 

  48. Olsson MJ, Juhlin L. Long-term follow-up of leucoderma patients treated with transplants of autologous cultured melanocytes, ultrathin epidermal sheets and basal cell layer suspension. Br J Dermatol. 2002;147:893–904.

    Article  CAS  PubMed  Google Scholar 

  49. Spitz JL. Genodermatoses: a clinical guide to genetic skin disorders. Philadelphia: Lippincott Williams & Wilkins; 2005.

    Google Scholar 

  50. Boissy RE, Nordlund JJ. Molecular basis of congenital hypopigmentary disorders in humans: a review. Pigment Cell Res. 1997;10:12–24.

    Article  CAS  PubMed  Google Scholar 

  51. Tassabehji M, Newton YE, Liu XZ, Brady A, Donnai D, Krajewska-Walasek M, Murday V, Norman A, Obersztyn E, Reardon W, et al. The mutational spectrum in Waardenburg syndrome. Hum Mol Genet. 1995;4:2131–7.

    Article  CAS  PubMed  Google Scholar 

  52. Tassabehji M, Newton YE, et al. Waardenburg syndrometype 2 caused by mutations in the human microphthalmia (MZTF) gene. Nat Genet. 1994;8:251–5.

    Article  CAS  PubMed  Google Scholar 

  53. Laude TA. Approach to dermatologic disorders in black children. Semin Dermatol. 1995;14:15–20.

    Article  CAS  PubMed  Google Scholar 

  54. Moreno-Cruz B, Torres-Alvarez B, Hernandez-Blanco D, Castanedo-Cazares JP. Double-blind, placebo-controlled, randomized study comparing 0.0003% calcitriol with 0.1% tacrolimus ointments for the treatment of endemic pityriasis alba. Dermatol Res Pract. 2012;2012:303275.

    PubMed  PubMed Central  Google Scholar 

  55. Silverberg NB. Pityriasis alba. In: Irvine AD, Hoeger PH, Yan AC, editors. Harper’s textbook of pediatric dermatology. 3rd ed. Hoboken: Wiley-Blackwell; 2011.

    Google Scholar 

  56. Di Fonzo EM, Martini P, Mazzatenta C, Lotti L, Alvino S. Comparative efficacy and tolerability of Ketomousse (ketoconazole foam 1%) and ketoconazole cream 2% in the treatment of pityriasis versicolor: results of a prospective, multicentre, randomised study. Mycoses. 2008;5:532–5.

    Article  Google Scholar 

  57. Gupta AK, Lane D, Paquet M. Systematic review of systemic treatments for tinea versicolor and evidence-based dosing regimen recommendations. J Cutan Med Surg. 2014;18:79–90.

    Article  CAS  PubMed  Google Scholar 

  58. Hu SW, Bigby M. Pityriasis versicolor: a systematic review of interventions. Arch Dermatol. 2010;146:1132–40.

    Article  PubMed  Google Scholar 

  59. Pallure V, Ameline M, Plantin P, Bessis D. Terra firma-forme dermatosis. Ann Dermatol Venereol. 2013;140(11):693–8.

    Article  CAS  PubMed  Google Scholar 

  60. Pascoe D, Morell DS. Progressive truncal ‘dirty skin’: confluent and reticulated papillomatosis. Pediatr Ann. 2007;36(12):810. 812–3.

    Article  PubMed  Google Scholar 

  61. Laude TA, Kenney Jr JA, Prose NS, Treadwell PA, Resnick SD, Gosain S, et al. Skin manifestations in individuals of African or Asian descent. Pediatr Dermatol. 1996;13:158–68.

    Article  CAS  PubMed  Google Scholar 

  62. Slyper AH, Kashmer L, Huang WM, Re’em Y. Acanthosis nigricans, vitamin D, and insulin resistance in obese children and adolescents. J Pediatr Endocrinol Metab. 2014;27:1107–11.

    Article  CAS  PubMed  Google Scholar 

  63. Treadwell PA. Systemic conditions in children associated with pigmentary changes. Clin Dermatol. 2015;33:362–7.

    Article  PubMed  Google Scholar 

  64. Silverberg NB. Pediatric vitiligo. Pediatr Clin North Am. 2014;61(2):347–66.

    Article  PubMed  Google Scholar 

  65. Silverberg NB. Recent advances in childhood vitiligo. Clin Dermatol. 2014;32(4):524–30.

    Article  PubMed  Google Scholar 

  66. Jin Y, Birlea SA, Fain PR, Ferrara TM, Ben S, Riccardi SL, et al. Genome-wide association analyses identify 13 new susceptibility loci for generalized vitiligo. Nat Genet. 2012;44(6):676–80.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  67. Ingordo V, Cazzaniga S, Raone B, Digiuseppe MD, Musumeci ML, Fai D, et al. Circulating autoantibodies and autoimmune comorbidities in vitiligo patients: a multicenter Italian study. Dermatology. 2014;228(3):240–9.

    Article  CAS  PubMed  Google Scholar 

  68. Silverberg JI, Silverberg NB. Clinical features of vitiligo associated with comorbid autoimmune disease: a prospective survey. J Am Acad Dermatol. 2013;69(5):824–6.

    Article  PubMed  Google Scholar 

  69. Pagovich OE, Silverberg JI, Freilich E, Silverberg NB. Thyroid abnormalities in pediatric patients with vitiligo in New York City. Cutis. 2008;81(6):463–6.

    PubMed  Google Scholar 

  70. Silverberg JI, Silverberg AI, Malka E, Silverberg NB. A pilot study assessing the role of 25 hydroxy vitamin D levels in patients with vitiligo vulgaris. J Am Acad Dermatol. 2010;62(6):937–41.

    Article  CAS  PubMed  Google Scholar 

  71. Silverberg N. Segmental vitiligo may not be associated with risk of autoimmune thyroiditis. Skinmed. 2011;9(5):329–30.

    PubMed  Google Scholar 

  72. Silverberg NB, Lin P, Travis L, Farley-Li J, Mancini AJ, Wagner AM, et al. Tacrolimus ointment promotes repigmentation of vitiligo in children: a review of 57 cases. J Am Acad Dermatol. 2004;51(5):760–6.

    Article  PubMed  Google Scholar 

  73. Happle R. Superimposed segmental manifestation of polygenic skin disorders. J Am Acad Dermatol. 2007;57:690–9.

    Article  PubMed  Google Scholar 

  74. Silverberg JI, Silverberg NB. Quality of life impairment in children and adolescents with vitiligo. Pediatr Dermatol. 2014;31(3):309–18.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Johns Hopkins Department of Dermatology, 200 North Wolfe Street, Unit 2107, Baltimore, MD, 21287, USA

    Candrice Heath

  2. Department of Dermatology, Mt. Sinai St. Luke’s, Roosevelt and Beth Israel Hospitals, 1090 Amsterdam Ave, Suite 11B, New York, NY, 10025, USA

    Nanette Silverberg

Authors
  1. Candrice Heath
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Nanette Silverberg
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Candrice Heath .

Editor information

Editors and Affiliations

  1. Stanford University School of Medicine, Stanford, California, USA

    Joyce M.C. Teng

  2. Stanford University School of Medicine, Stanford, California, USA

    Ann L. Marqueling

  3. Pediatric Dermatology, Joe DiMaggio Children’s Hospital, Hollywood, Florida, USA

    Latanya T. Benjamin

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Heath, C., Silverberg, N. (2017). Disorders of Pigmentation. In: Teng, J., Marqueling, A., Benjamin, L. (eds) Therapy in Pediatric Dermatology. Springer, Cham. https://doi.org/10.1007/978-3-319-43630-2_11

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-43630-2_11

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-43628-9

  • Online ISBN: 978-3-319-43630-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation